The IMF’s Understanding series of cancer information booklets is designed to acquaint you with specific multiple myeloma-related tests, treatments and therapies, supportive care measures, and common adverse events.

Order Print Edition


Full of our informative publications, including our Patient Handbook and selections from the popular Understanding Series, the Info Pack will…

This publication focuses on therapies (such as bisphosphonates) given to patient with myeloma bone lesions, lytic lesions, or myeloma bone disease.
This publication discusses what myeloma patients should consider if enrolling in a clinical trial.
This booklet discusses dexamethasone, a synthetic steroid that is one of the most frequently used medica­tions in the treatment of myeloma. It can be…
This publication discusses the use of Empliciti (elotuzumab)—a monoclonal antibody—for the treatment of myeloma.

with support from:

Johnson & Johnson and Pfizer.

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.